+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

S1004 Clearance of Hcv in Children At 5-Year Follow-Up Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment with Interferon Alfa-2b Plus Ribavirin



S1004 Clearance of Hcv in Children At 5-Year Follow-Up Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment with Interferon Alfa-2b Plus Ribavirin



Gastroenterology 134(4): A-773




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067059581

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(08)63609-4


Related references

S1001 Clearance of Hcv At 5 Year Follow-Up for Peginterferon Alfa-2b Ribavirin Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment. Gastroenterology 134(4): A-772, 2008

Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon alfa-2a and interferon alfa-2a. Hepatology 32(4 Pt 2): 356A, 2000

PEG-INTERFERON alpha-2B + RIBAVIRIN FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C WHO HAVE PREVIOUSLY FAILED TO ACHIEVE A SUSTAINED VIROLOGIC RESPONSE FOLLOWING INTERFERON ALFA OR INTERFERON A-2B + RIBAVIRIN THERAPY. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No T1292, 2003

Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin. Hepatology 51(4): 1122-1126, 2010

Sustained virologic response with albinterferon alfa-2b/ribavirin treatment in prior interferon therapy non-responders. 2007

Interferon-Free Regimens of Abt-450/R, Abt-267, Abt-333, and Ribavirin Achieve High Sustained Virologic Response 4 Weeks Post-Treatment (Svr4) Rates in Patients With Chronic Hcv Genotype 1 Regardless of Race, Ethnicity, or Other Baseline Characteristics. Gastroenterology 144(5): S-949, 2013

W1005 Hcv Rna At 12 Weeks After Treatment Can Predict Sustained Virologic Response in Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin. Gastroenterology 134(4): A-830, 2008

Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children. Medical Science Monitor 16(12): Cr616-Cr621, 2010

W1007 Rapid Virologic Response to Peginterferon Alfa and Ribavirin Treatment of Chronic Hepatitis C Predicts Sustained Virologic Response and Relapse. Gastroenterology 134(4): A-830, 2008

Is sustained virologic response durable in patients with chronic hepatitis C treated with interferon alfa with or without ribavirin?. Journal of Hepatology 36(Suppl. 1): 103, 2002

Rate of sustained virologic response with 24 vs 48 weeks of interferon plus ribavirin in HCV cirrhotics with genotype 2,3. Hepatology 38(4 Suppl 1): 748A, 2003

Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C. Scandinavian Journal of Gastroenterology 47(8-9): 1115-1119, 2012

Retreatment with initial daily interferon alfa-2b based on body surface area in combination with ribavirin leads to improved viral clearance in virologic nonresponders to standard therapy with interferon and ribavirin. Gastroenterology 120(5 Suppl. 1): A 380, 2001

Early virologic response value as predictive factor of sustained virologic response to treatment with interferon alpha-2b plus ribavirin in chronic hepatitis C patients with or without HIV coinfection. Medicina Clinica 127(15): 561-566, 2006

Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C. Journal of Hepatology 51(1): 21-28, 2009